Select Medical Stock Surges 8% on $3.9B Buyout Deal

SEM Shares Rise on $3.9B Executive-Led Buyout

Select Medical Holdings (NYSE:SEM) shares climbed 8% following the announcement of a definitive agreement to be acquired for $16.50 per share. The deal values the company at an enterprise value of $3.9 billion.

Details of the Acquisition Agreement

A consortium, led by Executive Chairman Robert A. Ortenzio and private equity firm Welsh, Carson, Anderson & Stowe, is leading the acquisition. The offer represents a significant premium over the company's prior trading prices, specifically 18% over the pre-proposal share price. Key executives will roll over their equity instead of receiving cash.

Impact on Select Medical and Shareholders

The transaction, expected to close in mid-2026, will result in Select Medical becoming a privately held company and its shares being delisted from the New York Stock Exchange. The deal is subject to shareholder and regulatory approvals but is not contingent on financing.

Transaction Outlook

The buyout awaits final shareholder and regulatory clearance. Analysts from Mizuho have described the $16.50 per share valuation as fair, reiterating an Outperform rating. The market will now watch for the completion of customary closing conditions.

FAQ

Q: What is the acquisition price for Select Medical stock?
A: The consortium will pay $16.50 per share in cash.

Q: When is the Select Medical buyout expected to close?
A: The transaction is expected to be completed in mid-2026, pending approvals.

Source: Investing.com